Sfoglia per RIVISTA
ANTICANCER RESEARCH
Collezione AOU San Luigi di Orbassano

  

Items : 33

Identifying the best candidates for salvage radical prostatectomy: EAU guidelines-compliant patients have better outcomes in Anticancer Research

2020
ASL Torino 4
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
ASL Città di Torino

Karnes RJ; Davis J; Lawrentschuk N; Murphy D; Tilki D; Van Der Poel H; Gill IS; Abreu A; Aron M; Berger A; Smith J; Mottrie A; Gandaglia G; Morlacco A; Albisinni S; Roupret M; De La Taille A; Piechaud T; Joniau S; Palou J; Persad R; Gillatt D; Cahill D; Popert R; Challacombe B; Dasgupta P; Goonewardene S; Sanchez-Salas R; Linares E; et alii...

Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis. in Anticancer research / Anticancer Res. 2019 Aug;39(8):4357-4361. doi: 10.21873/anticanres.13604.

2019
AOU San Luigi di Orbassano
ASL Città di Torino

Berruti A; Saad F; Briganti A; Simeone C; Shariat SF; Tian Z; Rosiello G; Knipper S; Pecoraro A; Palumbo C; Antonelli A; Karakiewicz PI;

Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study. in Anticancer research / Anticancer Res. 2019 Apr;39(4):1935-1942. doi: 10.21873/anticanres.13303.

2019
ASL Torino 4
AOU San Luigi di Orbassano
AO Cuneo

Russi EG; Alterio D; Osti MF; Valeriani M; Ruo Redda MG; Reali A; Maurizi F; Bunkhelia F; DE Felice F; Musio D; Muto P; Argenone A; Guarnaccia R; LA Porta MR; Caspiani O; Bacigalupo A; Belgioia L; Cante D; DE Sanctis V;

Comparing Image-guided targeted Biopsies to Radical Prostatectomy Specimens for Accurate Characterization of the Index Tumor in Prostate Cancer. in Anticancer research / Anticancer Res. 2018 May;38(5):3043-3047. doi: 10.21873/anticanres.12560.

2018
AOU San Luigi di Orbassano

Porpiglia F; DE Luca S; Checcucci E; Garrou D; Manfredi M; Mele F; Pecoraro A; Passera R; Bollito E; Fiori C;

Multi-parametric-magnetic resonance/ultrasound fusion prostate biopsy: Can the number and spatial distribution of cores play a role in the index tumor detection and characterization? in Anticancer Research

2018
AOU San Luigi di Orbassano

Porpiglia F; De Luca S; Manfredi M; Mele F; Bertolo R; Garrou D; Amparore D; Checcucci E; Gned D; De Pascale A; Bollito E; Fiori C;

Evaluation of the impact of minimally-invasive partial nephrectomy on renal volume and renal function: A prospective study in Anticancer Research

2018
AOU San Luigi di Orbassano

Porpiglia F; Bertolo R; Amparore D; Manfredi M; Mele F; Garrou D; Checcucci E; De Luca S; Veltri A; Bollito E; Tota D; Fiori C;

Comparison of mri-based and standard pathway for prostate cancer diagnosis: Three years result of a prospective randomized study in Anticancer Research

2018
AOU San Luigi di Orbassano

Porpiglia F; Manfredi M; Mele F; De Luca S; Bertolo R; Garrou D; Amparore D; Checcucci E; De Cillis S; De Pascale A; Gned D; Russo F; Cirillo S; Bollito E; Fiori C;

The role of operator in the detection rate of MRI/TRUS fusion transrectal prostate biopsy in Anticancer Research

2018
AOU San Luigi di Orbassano

Porpiglia F; Manfredi M; Mele F; De Luca S; Bertolo R; Garrou D; Amparore D; Checcucci E; De Cillis S; De Pascale A; Gned D; Russo F; Cirillo S; Bollito E; Tota D; Fiori C;

Prostate cancer and early biochemical recurrence: Which is the role of gallium-68-prostate specific membrane antigen positron emission tomography? in Anticancer Research

2018
AOU San Luigi di Orbassano

Porpiglia F; Fiori C; De Luca S; Manfredi M; Checcucci E; Alleva G; Garrou D; Amparore D; Bollito E;

Validation study about the role of 3D printed virtual models for robotassisted- radical-prostatectomy and partial-nephrectomy in Anticancer Research

2018
AOU San Luigi di Orbassano

Porpiglia F; Bertolo R; Manfredi M; Mele F; Amparore D; Checcucci E; Garrou D; Cattaneo G; Gned D; Solitro F; Bollito E; Tota D; Fiori C;

Feasibility of prostate mri-trus fusion software-based targeted biopsy in an outpatient setting: Our results in Anticancer Research

2018
AOU San Luigi di Orbassano

Porpiglia F; Fiori C; Mele F; Manfredi M; Aimar R; Amparore D; Checcucci E; Garrou D; Tota D; Bollito E;

Widespread use of protocol-based active surveillance in prostate cancer: The siuro prias ITA experience in Anticancer Research

2018
AOU San Luigi di Orbassano

Badenchini F; Alvisi MF; Battaglia M; Enrico B; Borghesi M; Cicchetti G; Colombo P; Colecchia M; Cusumano G; Da Pozzo L; Di Tonno P; Diazzi D; Fiorentino M; Frego E; Gallucci M; Giliberti A; Guazzoni G; Hurle R; Jaeger T; Lapini A; Martorana G; Montironi R; Napodano G; Paolini B; Pasini L; Patriarca C; Raspollini MR; Roscigno M; Sanseverino R; et alii...

The role of prostate MRI 3D-reconstruction robot-assisted radical prostatectomy in reducing positive surgical margin rate in Anticancer Research

2017
AOU San Luigi di Orbassano

Porpiglia F; Manfredi M; Checcucci E; Mele F; Bertolo R; De Luca S; Garrou D; Cattaneo G; Amparore D; Bollito E; Fiori C;

Prospective randomized controlled trial comparing laparoscopic versus robot-assisted radical prostatectomy: Outcomes after five-year follow-up in Anticancer Research

2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Porpiglia F; Fiori C; Bertolo R; Manfredi M; Mele F; Garrou D; Cattaneo G; Checcucci E; Amparore D; De Luca S; Passera R; Bollito E; Scarpa RM;

Fusion targeted biopsy may improve the agreement between bioptical and pathological Gleason score in Anticancer Research

2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Porpiglia F; Passera R; Mele F; Manfredi M; Bertolo R; Garrou D; Checcucci E; Amparore D; Cattaneo G; Bollito E; Cirillo S; De Pascale A; Russo F; De Luca S;

Is mri helpful in lymph node invasion detection in addition to Briganti updated nomogram? in Anticancer Research

2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Porpiglia F; Manfredi M; Bertolo R; Cattaneo G; Checcucci E; Amparore D; Garrou D; Passera R; De Luca S; Gned D; Veltri A; Regge D; Russo F; Cirillo S; Bollito E; Fiori C;

Pain control during prostate MRI-TRUS fusion software-based targeted biopsy in Anticancer Research

2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Porpiglia F; Mele F; Manfredi M; De Luca S; Checcucci E; Amparore D; Cattaneo G; Garrou D; Bollito E; Russo F; De Pascale A; Gned D; Cirillo S; Fiori C;

Our experience with t1 renal masses: Results after 600 laparoscopic partial nephrectomies in Anticancer Research

2017
AOU San Luigi di Orbassano

Porpiglia F; Bertolo R; Amparore D; Checcucci E; Garrou D; Manfredi M; Mele F; Cattaneo G; De Cillis S; Morra I; Fiori C;

Management of fusion prostate biopsy looking for a better index tumor detection and characterization in Anticancer Research

2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Porpiglia F; De Luca S; Passera R; De Pascale A; Amparore D; Cattaneo G; Checcucci E; Bertolo R; De Cillis S; Garrou D; Manfredi M; Mele F; Bollito E; Fiori C;

Pre-surgical assessment of extraprostatic invasion using prostate MRI: Update after 400 cases in Anticancer Research

2017
AOU San Luigi di Orbassano

Bollito E; Manfredi M; Mele F; Bertolo R; Cattaneo G; Garrou D; Volante M; Veltri A; De Pascale A; Gned D; Russo F; Cirillo S; Fiori C; Porpiglia F;

CT2 kidney cancer: Could be managed with an organ-sparing approach? in Anticancer Research

2017
AOU San Luigi di Orbassano

Porpiglia F; Bertolo R; Amparore D; Piramide F; Manfredi M; Mele F; Curologiaheccucci E; De Cillis S; Bollito E; Fiori C;

Metastatic castration-resistant prostate cancer (MCRPC) patients long term responders (LTR) to the a new agent (NA)-based second line: Clinical outcomes and prognostic factors of subsequent treatment with another NA in Anticancer Research

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Galli L; Fratino L; Facchini G; Iacovelli R; Mucciarini C; Zucali PA; Vicario G; Carrozza F; Sirotova Z; Messina C; Bordonaro R; La Torre L; Sacco C; Veccia A; Sperduti I; Zagonel V;

Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in metastatic castration resistant prostate cancer (MCRPC) patients receiving a new agent (NA)-based third-line treatment. Final results from a multicenter Italian study in Anticancer Research

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Galli L; Fratino L; Facchini G; Iacovelli R; Re GL; Mosillo C; Gasparro D; Guglielmini P; Damiani A; Procopio G; De Lisi D; Ortega C; Scagliarini S; Donini M; Sperduti I; Basso U;

Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score. in Anticancer research / Anticancer Res. 2016 Sep;36(9):4833-9. doi: 10.21873/anticanres.11045.

2016
AOU San Luigi di Orbassano

Porpiglia F; DE Luca S; Passera R; Manfredi M; Mele F; Bollito E; DE Pascale A; Cossu M; Aimar R; Veltri A;

Bioequivalence of branded and generic oxaliplatin: From preclinical assessment to clinical incidence of hypersensitivity reactions in Anticancer Research

2016
AOU San Luigi di Orbassano

Tampellini M; Benedetto S; Rubatto E; Baratelli C; Di Scipio F; Pirro E; Brizzi MP; Sonetto C; Di Maio M; Berta GN; Scagliotti GV;

Pathological patterns of prostate biopsy in men with fluctuations of prostate cancer gene 3 score: a preliminary report. in Anticancer research / Anticancer Res. 2015 Apr;35(4):2417-22.

2015
AOU San Luigi di Orbassano

De Luca S; Passera R; Cappia S; Bollito E; Randone DF; Porpiglia F;

Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy. in Anticancer research / Anticancer Res. 2014 Dec;34(12):7159-65.

2014
AOU San Luigi di Orbassano

De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F;

Biopsy and radical prostatectomy pathological patterns influence prostate cancer gene 3 (PCA3) in Anticancer Research

2013
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

De Luca S; Passera R; Bollito E; Milillo A; Scarpa RM; Papotti M; Coda R; Randone DF;

The prognostic role of molecular testing in patients with prostate cancer: A preliminary study in Anticancer Research

2013
AOU San Luigi di Orbassano

Bollito E; Manfredi M; Duregon E; Freschi M; Scattoni V; Papotti M; Porpiglia F;

Pure versus robotic assisted laparoscopic prostatectomy: Is there a difference in terms of positive surgical margins during the “learning curve”? in Anticancer Research

2012
AOU San Luigi di Orbassano

Fiori C; Chiarissi ML; Morra I; Bertolo R; Manfredi M; Mele F; Poggio M; Grande S; Garrou D; Porpiglia F;

Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients. in Anticancer research / Anticancer Res. 2008 Sep-Oct;28(5B):3055-60.

2008
AOU San Luigi di Orbassano

Bitossi R; Sculli CM; Tampellini M; Alabiso I; Brizzi MP; Ferrero A; Ottone A; Bellini E; Gorzegno G; Berruti A; Dogliotti L;

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients. in Anticancer research / Anticancer Res. 2005 Nov-Dec;25(6C):4475-9.

2005
AOU San Luigi di Orbassano

Berruti A; Mosca A; Bitossi R; Gorzegno G; Guercio S; Poggio M; Tampellini M; Porpiglia F; Ostellino O; Scarpa RM; Dogliotti L;

Biochemical picture of bone metabolism in breast cancer patients with bone metastases. in Anticancer research / Anticancer Res. 1995 Nov-Dec;15(6B):2871-5.

1995
AOU San Luigi di Orbassano

Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A;